James E. Muntz, MD

Professor of Clinical Medicine, Institute for Academic Medicine
Houston Methodist
Weill Cornell Medical College


Education & Training

MD, Baylor College of Medicine
Residency, Baylor College of Medicine
Publications

Evaluation and Pharmacokinetics of Treatment Dose Enoxaparin in Hospitalized Patients with Morbid Obesity
Thompson-Moore, NR, Wanat, MA, Putney, DR, Liebl, PHN, Chandler, WL & Muntz, JE 2015, Clinical and Applied Thrombosis/Hemostasis, vol. 21, no. 6, pp. 513-520. DOI: 10.1177/1076029614568713

Thromboprophylaxis in day surgery: Knee arthroscopy and ligamentoplasty (Ligament Reconstruction)
Muntz, JE, Flores, SE & Lowe, WR 2014, . in Thromboembolism in Orthopedic Surgery. vol. 9781447143369, Springer-Verlag London Ltd, pp. 123-132. DOI: 10.1007/978-1-4471-4336-9_10

Deep vein thrombosis and pulmonary embolism in patients undergoing total hip arthroplasty: the promise of new oral anticoagulants.
Muntz, J 2011, Journal of surgical orthopaedic advances, vol. 20, no. 4, pp. 215-219.

Duration of deep vein thrombosis prophylaxis in the surgical patient and its relation to quality issues
Muntz, J 2010, American journal of surgery, vol. 200, no. 3, pp. 413-421. DOI: 10.1016/j.amjsurg.2009.05.045

Prevention and management of venous thromboembolism in the surgical patient: options by surgery type and individual patient risk factors.
Muntz, JE & Michota, FA 2010, American journal of surgery, vol. 199, no. 1 Suppl.

Thromboprophylaxis in orthopedic surgery: how long is long enough?
Muntz, J 2009, American journal of orthopedics (Belle Mead, N.J.), vol. 38, no. 8, pp. 394-401.

Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: A review
Huo, MH & Muntz, J 2009, Clinical Therapeutics, vol. 31, no. 6, pp. 1129-1141. DOI: 10.1016/j.clinthera.2009.06.002

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
Kakkar, AK, Brenner, B, Dahl, OE, Eriksson, BI, Mouret, P, Muntz, J, Soglian, AG, Pap, ÁF, Misselwitz, F & Haas, S 2008, The Lancet, vol. 372, no. 9632, pp. 31-39. DOI: 10.1016/S0140-6736(08)60880-6

Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: A randomized, double-blind comparison
Turpie, AGG, Bauer, KA, Caprini, JA, Comp, PC, Gent, M & Muntz, JE 2007, Journal of Thrombosis and Haemostasis, vol. 5, no. 9, pp. 1854-1861. DOI: 10.1111/j.1538-7836.2007.02657.x

Factors associated with thromboprophylaxis for orthopedic patients and their impact on outcome.
Muntz, JE, OConnor, PJ, Yin, H & Vogenberg, FR 2007, American journal of orthopedics (Belle Mead, N.J.), vol. 36, no. 4, pp. 193-197.

Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: The REGIMEN registry
Spyropoulos, AC, Turpie, A, Dunn, AS, Spandorfer, J, Douketis, J, Jacobson, A, Frost, FJ, West, M, Green, D, Campbell, M, Krasuski, R, Ortel, T, OShea, S, Deitelzweig, S, Muntz, J, Spencer, F, Jafri, S & Kaatz, S 2006, Journal of Thrombosis and Haemostasis, vol. 4, no. 6, pp. 1246-1252. DOI: 10.1111/j.1538-7836.2006.01908.x

Treatment of venous thromboembolism in orthopaedic surgery
Muntz, JE 2004, Techniques in Orthopaedics, vol. 19, no. 4, pp. 337-346. DOI: 10.1097/01.bto.0000145152.94857.9d

Fondaparinux for prophylaxis
Muntz, JE 2004, Techniques in Orthopaedics, vol. 19, no. 4, pp. 278-282. DOI: 10.1097/01.bto.0000145153.77263.db

Major bleeding rates after prophylaxis against venous thromboembolism: Systematic review, meta-analysis, and cost implications
Muntz, J, Scott, DA, Lloyd, A & Egger, M 2004, International Journal of Technology Assessment in Health Care, vol. 20, no. 4, pp. 405-414.

A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: Use in patients undergoing major orthopaedic surgery
Sullivan, SD, Davidson, BL, Kahn, SR, Muntz, JE, Oster, G & Raskob, G 2004, PharmacoEconomics, vol. 22, no. 9, pp. 605-620. DOI: 10.2165/00019053-200422090-00005

Safety syringes can reduce the risk of needlestick injury in venous thromboembolism prophylaxis.
Muntz, JE & Hultburg, R 2004, J Surg Orthop Adv, vol. 13, no. 1, pp. 15-19.

Orthopedic pearls in deep vein thrombosis: questions frequently asked.
Muntz, JE 2003, J Surg Orthop Adv, vol. 12, no. 4, pp. 225-227.

The risk of venous thromboembolism in non-large-joint surgeries
Muntz, JE 2003, Orthopedics, vol. 26, no. 2 SUPPL..

Thromboprophylaxis dosing: the relationship between timing of first administration, efficacy, and safety.
Kwong, LM & Muntz, JE 2002, American journal of orthopedics (Belle Mead, N.J.), vol. 31, no. 11 Suppl, pp. 16-20.

Advances in deep vein thrombosis treatment.
Muntz, JE 2002, Surgical technology international, vol. 10, pp. 249-253.